phosphorylcholine has been researched along with itraconazole in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Barragán, P; López-Velez, R; Olmo, M; Podzamczer, D | 1 |
Borba-Santos, LP; de Souza, W; Gagini, T; Ishida, K; Rozental, S | 1 |
Braga, SS | 1 |
Bunker, A; Dzieciuch-Rojek, M; Kepczynski, M; Poojari, C; Róg, T; Zak, A | 1 |
El-Khordagui, LK; El-Moslemany, RM; El-Sheridy, NA; Helmy, MW; Ramadan, AA | 1 |
1 review(s) available for phosphorylcholine and itraconazole
Article | Year |
---|---|
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
4 other study(ies) available for phosphorylcholine and itraconazole
Article | Year |
---|---|
Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.
Topics: AIDS-Related Opportunistic Infections; HIV; HIV Infections; HIV-1; Humans; Itraconazole; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Opportunistic Infections; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Recurrence; Treatment Failure | 2010 |
Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole.
Topics: Amphotericin B; Animals; Antifungal Agents; Brazil; Cell Line; Cell Membrane; Cell Survival; Cell Wall; Cytoplasm; Drug Resistance, Fungal; Epithelial Cells; Humans; Itraconazole; Macaca mulatta; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Phosphorylcholine; Sporothrix; Sporotrichosis | 2015 |
Cholesterol Reduces Partitioning of Antifungal Drug Itraconazole into Lipid Bilayers.
Topics: Antifungal Agents; Cholesterol; Glycerol; Itraconazole; Lipid Bilayers; Phosphatidylcholines; Phosphorylcholine | 2020 |
Enhancing the
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Combinations; Drug Liberation; Female; Hedgehog Proteins; Humans; Itraconazole; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanocapsules; Neovascularization, Pathologic; Particle Size; Phosphorylcholine; Random Allocation | 2021 |